广发纳斯达克生物科技人民币(001092)
动态评分: 5.23分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2021-06-30 | MGTA | Magenta Therapeutics Inc | 4.33 | 0.04% |
2021-06-30 | ARDX | Ardelyx Inc | 5 | 0.04% |
2021-06-30 | MRNS | Marinus Pharmaceuticals Inc | 4.61 | 0.04% |
2021-06-30 | ORIC | Oric Pharmaceuticals Inc | 4.79 | 0.04% |
2021-06-30 | PAHC | 美国辉宝 | 4.31 | 0.04% |
2021-06-30 | AKBA | Akebia Therapeutics Inc | 4.75 | 0.04% |
2021-06-30 | PASG | Passage BIO Inc | 4.94 | 0.04% |
2021-06-30 | CLVS | Clovis Oncology Inc | 4.57 | 0.04% |
2021-06-30 | ADAP | Adaptimmune Therapeutics plc ADR | 4.28 | 0.04% |
2021-03-31 | AMGN | 安进 | 639.94 | 6.38% |
2021-03-31 | GILD | 吉利德科学 | 594.88 | 5.93% |
2021-03-31 | VRTX | 福泰制药 | 420.53 | 4.19% |
2021-03-31 | ILMN | Illumina Inc | 400.78 | 4% |
2021-03-31 | MRNA | Moderna Inc | 365.37 | 3.64% |
2021-03-31 | REGN | 再生元制药 | 363.46 | 3.62% |
2021-03-31 | BIIB | 生化基因 | 303.69 | 3.03% |
2021-03-31 | ALXN | 亚力兄制药 | 245.07 | 2.44% |
2021-03-31 | SGEN | Seagen Inc | 187.97 | 1.87% |
2021-03-31 | AZN | 阿斯利康(US ADR) | 179.76 | 1.79% |
2020-12-31 | GILD | 吉利德科学 | 600.47 | 5.97% |
公告&资料
